BUSINESS

• Eylea Bio-AG Snags 60% Share in Just 3 Months, Outpacing Biosimilar
  May 29, 2026

• FRONTEO, Scohia Team Up on AI-Driven Indication Discovery
  May 29, 2026

• AGC Biologics Launches Bispecific Antibody CDMO Project in Japan
  May 28, 2026

• Bayer Regulatory Chief Hails Japan’s Review System, Flexibility on PI Waivers
  May 28, 2026

• Asahi Kasei Licenses ADC Technology from Noguchi Institute
  May 28, 2026

• Kissei Files Rigel’s AML Drug Olutasidenib in Japan
  May 28, 2026

• Japan OTC Market Falls 2.4% in April amid Weaker Inbound Demand: Intage
  May 28, 2026

• Astellas Sees Sales Decline through FY2029 on Xtandi LOE, Maps 200 Billion Yen Cuts in 5 Years
  May 27, 2026

• ASKA Set to Seek Shareholder OK for Faster Poison Pill Activation
  May 27, 2026

• Eylea Biosimilar Shipment Restrictions to Be Lifted on June 5
  May 27, 2026

• Bayer’s Low-Dose MRI Contrast Agent Ambelvist Debuts in Japan
  May 27, 2026

• Eisai Eyes 1 Trillion yen in FY2028 Sales under 3-Year Plan
  May 26, 2026

• Nippon Kayaku to Take Over AstraZeneca’s Zoladex in Japan
  May 26, 2026

• Jardiance Triumphs in Six Promotion Channels in April: Intage
  May 26, 2026

• NTT Data, Kindai Hospital Validate RWD-Based Patient Screening Technology
  May 26, 2026

• Enhertu Earns EMA Panel OK for HER2 Positive Solid Tumors
  May 25, 2026

• Datroway Snares US Approval in 1st-Line TNBC: Daiichi Sankyo
  May 25, 2026

• Net Profit at 24 Japan Drug Makers Tops 2 Trillion Yen, Led by Astellas and Sumitomo
  May 25, 2026

• Padcev-Keytruda Gets CHMP Nod for Cisplatin-Ineligible Bladder Cancer
  May 25, 2026

• Japan Market Hits Record 11.8 Trillion Yen in FY2025, Keytruda Keeps Title: IQVIA
  May 22, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »